Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice

Life Sciences

Volumn 76, Issue 6, 2004, Pages 685-697

  Pascutti, María Fernanda ^a   Pitashny, Milena ^a   Nocito, Ana Lía ^a   Guermonprez, Pierre ^b   Amigorena, Sebastian ^b   Wietzerbin, Juana ^b   Serra, Esteban ^c   Bottasso, Oscar ^a   Revelli, Silvia ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b INSERM   (France)

^c Instituto de Biologia Molecular y Celular de Rosario   (Argentina)

Author keywords

Benznidazole; Cytokines; Experimental endotoxemia; Inducible nitric oxide synthase

Indexed keywords

BENZNIDAZOLE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; INFLAMMATION; LETHALITY; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHAGAS DISEASE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROIMIDAZOLES; PERITONEAL LAVAGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRYPANOCIDAL AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 9644258953     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.09.013     Document Type: Article

References (42)

1. S. Akira, T. Taga, and T. Kishimoto Interleukin-6 in biology and medicine Advances in Immunology 54 1993 1 78
2. P.J. Barnes, and M. Karin Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases The New England Journal of Medicine 336 15 1997 1066 1071
3. C. Becker, S. Wirtz, X. Ma, M. Blessing, P.R. Galle, and M.F. Neurath Regulation of IL-12 promoter activity in primary human monocytes: Roles of NF-κB, C-EBP, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and PGE2 Journal of Immunology 167 5 2001 2608 2618
4. D.J. Berg, R. Kuhn, K. Rajewsky, W. Muller, S. Menon, N. Davidson, G. Grunig, and D. Rennick Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Schwartzman reaction but not endotoxin tolerance The Journal of Clinical Investigation 96 5 1995 2339 2347
5. B. Beutler Tlr4: central component of the sole mammalian LPS sensor Current Opinion in Immunology 12 1 2000 20 26
6. C. Bogdan Nitric oxide and the immune response Nature Immunology 2 10 2001 907 916
7. D.S. Bredt, and S.H. Snyder Nitric Oxide: A physiologic messenger molecule Annual Review of Biochemistry 63 1994 175 195
8. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 6 1996 2095 2147
9. M.A. Dobrovolskaia, and S.N. Vogel Toll receptors, CD14 and macrophage activation and deactivation by LPS Microbes and Infection 4 9 2002 903 914
10. J.C. Drapier, J. Wietzerbin, and J.B. Hibbs IFN-γ and TNF-α induce the L-argininedependent cytotoxic effector mechanism in murine macrophages European Journal of Immunology 18 10 1988 1587 1592
11. T.S. Finco, and A.S. Baldwin Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis Immunity 3 3 1995 263 272
12. R.T. Gazzinelli, I.P. Oswald, S. Hieny, S.L. James, and A. Sher The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an Larginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β European Journal of Immunology 22 10 1992 2501 2506
13. M.P. Glauser, G. Zanetti, J.D. Baumgartner, and J. Cohen Septic shock: pathogenesis Lancet 338 8769 1991 732 736
14. J.C. Gutierrez-Ramos, and H. Bluethmann Molecules and mechanisms operating in septic shock: lessons from knockout mice Immunology Today 18 7 1997 329 334
15. C.E. Hack, L.A. Aarden, and L.G. Thijs Role of cytokines in sepsis Advances in Immunology 66 1997 101 195
16. D. Heumann, M.P. Glauser, and T. Calandra Molecular basis of host-pathogen interaction in septic shock Current Opinion in Microbiology 1 1 1998 49 55
17. M. Howard, T. Muchamuel, S. Andrade, and S. Menon Interleukin 10 protects mice from lethal endotoxemia Journal of Experimental Medicine 177 4 1993 1205 1208
18. C.J. Lowenstein, E.W. Alley, P. Raval, A.M. Snowman, S.H. Snyder, S. Russell, and W.J. Murphy Macrophage nitric oxide synthase gene: two uptreams regions mediate induction by interferon γ and lipopolysaccharide Proceedings of the National Academy of Sciences of the United States of America 90 20 1993 9730 9734
19. J. MacMicking, Q. Xie, and C. Nathan Nitric oxide and macrophage function Annual Review of Immunology 15 1997 323 350
20. A. Marchant, C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia European Journal of Immunology 24 5 1994 1167 1171
21. P.R. Mayeux Pathobiology of lipopolysaccharide Journal of Toxicology and Environmental Health 51 5 1997 415 435
22. F. Mercurio, and A.M. Manning Multiple signals converging to NF-κB Current Opinion in Cell Biology 11 2 1999 226 232
23. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacological Reviews 43 2 1991 109 142
24. D.C. Morrison, and J.L. Ryan Endotoxin and disease mechanisms Annual Review of Medicine 38 1987 417 432
25. T.L. Murphy, M.G. Cleveland, P. Kulesza, J. Magram, and K.M. Murphy Regulation of Interleukin 12 p40 expression through an NF-κB half-site Molecular and Cellular Biology 15 10 1995 5258 5267
26. S.M.F. Murta, C. Ropert, R.O. Alves, R.T. Gazzinelli, and A.J. Romanha In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a dereived drug-resistant Trypanosoma cruzi population Parasite Immunology 21 10 1999 535 544
27. A.K. Nussler, M. Di Silvio, T.R. Billiar, R.A. Hoffman, D.A. Geller, R. Selby, J. Madariaga, and R.L. Simmons Stimulation of the nitric oxide synthase pathway in human hepatocytes and endotoxin The Journal of Experimental Medicine 176 1 1992 261 264
28. A.K. Nussler, D.A. Geller, M.A. Sweetland, M. Di Silvio, T.R. Billiar, J.B. Madariaga, R.L. Simmons, and J.R. Lancaster Induction of nitric oxide synthesis and its reactions in culltured human and rat hepatocytes stimulated with cytokines plus LPS Biochemical and Biophysical Research Communications 194 2 1993 826 835
29. C. Pellat-Deceunynck, J. Wietzerbin, and J.C. Drapier Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages The Biochemical Journal 297 1994 53 58
30. P. Petray, E. Castaños-Velez, S. Grinstein, A. Örn, and M.E. Rottenberg Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi Immunology Letters 47 1-2 1995 121 126
31. E. Piaggio, E. Roggero, M. Pitashny, J. Wietzerbin, O. Bottasso, and S. Revelli Treatment with benznidazol and its immunomodulating effects on experimentally Trypanosoma cruzi-infected rats Parasitology Research 87 7 2001 539 547
32. E. Piaggio, J. Sanceau, S. Revelli, O. Bottasso, J. Wietzerbin, and E. Serra Trypanocidal drug Benznidazol impairs lipopolysaccharide induction of macrophage nitric oxide synthase gene transcription trough inhibition of NF-κB activation Journal of Immunology 167 6 2001 3422 3426
33. S.T. Qureshi, L. Lariviere, G. Leveque, S. Clermont, K.J. Moore, P. Gros, and D. Malo Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4) The Journal of Experimental Medicine 189 4 1999 615 625
34. S. Revelli, C. Le Page, E. Piaggio, J. Wietzerbin, and O. Bottasso Benznidazole, a drug employed in the treatment of Chagas' disease, down regulates the synthesis of nitrite and cytokines by murine stimulated macrophages Clinical and Experimental Immunology 118 2 1999 271 277
35. A.J. Romanha, R.O. Alves, S.M.F. Murta, J.S. Silva, C. Ropert, and R.T. Gazzinelli Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-γ in mediating parasitologic cure Journal of Infectious Diseases 186 6 2002 823 828
36. C.A. Salkowski, G. Detore, R. McNally, N. Van Rooynen, and S.N. Voge Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo Journal of Immunology 158 2 1997 905 912
37. C. Thiemermann The role of the L-arginine: nitric oxide pathway in circulatory shock Advances in Pharmacology 28 1994 45 79
38. L.G. Thijs, A.B. Groeneveld, and C.E. Hack Multiple organ failure in septic shock Current Topics in Microbiology and Immunology 216 1996 209 237
39. G. Trinchieri Interleukin-12: a cytokine at the interface of inflammation and immunity Advances in Immunology 70 1998 83 243
40. P. Vassalli The pathophysiology of tumor necrosis factors Annual Review of Immunology 10 1992 411 452
41. S.D. Wright, P.S. Tobias, R.J. Ulevitch, and R.A. Ramos Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages The Journal of Experimental Medicine 170 4 1989 1231 1241
42. S.D. Wright, R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 4975 1990 1431 1433